| dc.contributor.author | Edwards, AE | |
| dc.contributor.author | Vathenen, R | |
| dc.contributor.author | Henson, SM | |
| dc.contributor.author | Finer, S | |
| dc.contributor.author | Gunganah, K | |
| dc.date.accessioned | 2021-07-12T12:00:15Z | |
| dc.date.available | 2021-07-12T12:00:15Z | |
| dc.date.issued | 2021-06-29 | |
| dc.identifier.citation | Edwards, AE, Vathenen, R, Henson, SM, Finer, S, Gunganah, K. Acute hyperglycaemic crisis after vaccination against COVID-19: A case series. Diabet Med. 2021; 00:e14631. https://doi.org/10.1111/dme.14631 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/73004 | |
| dc.description.abstract | Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the most important component of the global response to the COVID-19 pandemic. Although most adverse reactions observed have been mild, the emergence of more serious vaccine-associated adverse events is being closely monitored. | en_US |
| dc.format.extent | e14631 | |
| dc.language | eng | |
| dc.relation.ispartof | Diabetic Medicine | |
| dc.title | Acute hyperglycaemic crisis after vaccination against COVID-19: A case series. | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1111/dme.14631 | |
| pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/34185927 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published online | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
